Aer Therapeutics Stock

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Sign up today and learn more about Aer Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Aer Therapeutics Stock

Aer Therapeutics is a clinical-stage biopharmaceutical company that develops an approach to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with significant unmet needs, such as COPD, cystic fibrosis, and asthma.

Funding History

April 2023$36.0M


Board Member and Founder

John Fahy

Board of Directors

Rishi Gupta

Board of Directors

Thomas Mathers

Board of Directors

Timothy Shannon

Board of Directors

Christy L. Shaffer


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: